AlzeCure Pharma (ALZCUR) — Financial Flexibility Index
AlzeCure Pharma (ALZCUR) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of Skr-7.62 Million (operating CF Skr-7.62 Million minus capex Skr0.00) represents 0% of total liabilities (Skr15.93 Million). Check AlzeCure Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AlzeCure Pharma Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for AlzeCure Pharma across 8 annual periods. For the full cash flow conversion analysis, see AlzeCure Pharma (ALZCUR) cash flow conversion.
Annual Financial Flexibility Index for AlzeCure Pharma (2017–2024)
Year-by-year free cash flow to debt coverage for AlzeCure Pharma. Explore AlzeCure Pharma (ALZCUR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.24x | Skr-35.00 Million | Skr-35.12 Million | Skr8.25 Million | ▼ -1241.7% |
| 2023 | 0.37x | Skr3.06 Million | Skr3.06 Million | Skr8.23 Million | ▲ +103.9% |
| 2022 | -9.65x | Skr-99.91 Million | Skr-99.91 Million | Skr10.35 Million | ▼ -73.2% |
| 2021 | -5.57x | Skr-70.58 Million | Skr-70.64 Million | Skr12.67 Million | ▲ +42.8% |
| 2020 | -9.73x | Skr-68.84 Million | Skr-69.51 Million | Skr7.07 Million | ▲ +5.3% |
| 2019 | -10.28x | Skr-48.82 Million | Skr-50.28 Million | Skr4.75 Million | ▼ -32.4% |
| 2018 | -7.76x | Skr-35.81 Million | Skr-36.27 Million | Skr4.61 Million | ▼ -294.8% |
| 2017 | -1.97x | Skr-8.15 Million | Skr-8.42 Million | Skr4.15 Million | — |